News
15h
Indian Defence Review on MSNAn AI That Could ‘Solve All Diseases’ Prepares for First Human Drug TrialsIsomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...
In this episode presented by IQVIA, BioSpace's head of insights Lori Ellis discusses the evolving role of local qualified ...
In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...
Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...
Onda on Wednesday launched a free ap for surfers that personalizes local weather forecasts and community updates, starting ...
Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...
Historian Niall Ferguson warns against unlimited access to AI tools for those under 25, calling it a disaster for brain development.
One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.
Wayve was among the first unicorn AI startups in the UK, getting funding of over $1 billion for its self-driving artificial ...
At the latest Capitol Weekly-University of California Student and Policy Center conference this week, “California and AI,” ...
As AI becomes central, the ability to ask the right question isn’t just a technical skill but a foundational one.
Grok 4 is xAI’s most advanced model yet, but early praise is clashing with old scandals and fresh tests of its limits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results